Polyoxometalates Impact as Anticancer Agents
International Journal of Molecular Sciences · 06.03.2023 · 24 (5) · 5043
DOI: 10.3390/ijms24055043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2023. Verfasst von Fátima Carvalho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina e Ciências Biomédicas (FMCB), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal. Hauptthemen laut MEDLINE: Antineoplastic Agents, Transition Elements. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT - Foundation for Science and Technology.
Abstract (Originalsprache)
Polyoxometalates (POMs) are oxoanions of transition metal ions, such as V, Mo, W, Nb, and Pd, forming a variety of structures with a wide range of applications. Herein, we analyzed recent studies on the effects of polyoxometalates as anticancer agents, particularly their effects on the cell cycle. To this end, a literature search was carried out between March and June 2022, using the keywords “polyoxometalates” and “cell cycle”. The effects of POMs on selected cell lines can be diverse, such as their effects in the cell cycle, protein expression, mitochondrial effects, reactive oxygen species (ROS) production, cell death and cell viability. The present study focused on cell viability and cell cycle arrest. Cell viability was analyzed by dividing the POMs into sections according to the constituent compound, namely polyoxovanadates (POVs), polyoxomolybdates (POMos), polyoxopaladates (POPds) and polyoxotungstates (POTs). When comparing and sorting the IC50 values in ascending order, we obtained first POVs, then POTs, POPds and, finally, POMos. When comparing clinically approved drugs and POMs, better results of POMs in relation to drugs were observed in many cases, since the dose required to have an inhibitory concentration of 50% is 2 to 200 times less, depending on the POMs, highlighting that these compounds could become in the future an alternative to existing drugs in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculdade de Medicina e Ciências Biomédicas (FMCB), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
- Faculdade de Ciências e Tecnologia (FCT), Universidade do Algarve, 8005-139 Faro, Portugal.
- Centro de Ciências do Mar (CCMar), Universidade do Algarve, 8005-139 Faro, Portugal.
ORCID-Profile: Manuel Aureliano
Förderung
- FCT - Foundation for Science and Technology
Zitieren
APA
Carvalho, F., & Aureliano, M. (2023). Polyoxometalates Impact as Anticancer Agents. International Journal of Molecular Sciences, 24(5), 5043. https://doi.org/10.3390/ijms24055043
Vancouver
Carvalho F, Aureliano M. Polyoxometalates Impact as Anticancer Agents. International Journal of Molecular Sciences. 2023;24(5):5043. doi:10.3390/ijms24055043
BibTeX
@article{Carvalho2023,
author = {Carvalho, Fátima and Aureliano, Manuel},
title = {Polyoxometalates Impact as Anticancer Agents},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {5043},
doi = {10.3390/ijms24055043}
}
EUVIMED